HIV vaccine acceptability: a systematic review and meta-analysis
Authors:
- Peter A NewmanPNPeter A Newman
- Carmen LogieCLCarmen Logie
- 17 July 2010
- journal article
- review article
- Published by Wolters Kluwer Health in AIDS
- Vol. 24 (11) , 1749-1756
Abstract
To conduct a systematic review of the literature to examine HIV vaccine acceptability and factors impacting acceptability of future HIV vaccines. Systematic review and meta-analysis of peer-reviewed articles that assessed HIV vaccine acceptability. We used a comprehensive search strategy across multiple electronic databases to locate original quantitative or qualitative studies that examined rates or correlates of HIV vaccine acceptability. We conducted meta-analysis on studies reporting correlates or predictors of HIV vaccine acceptability. Twenty studies (n=7576) reported HIV vaccine acceptability ranging from 37.2 to 94.0 on a 100-point scale; weighted mean acceptability =65.6 (SD=21.1). Eleven studies compared HIV vaccine acceptability at high (80-95%) efficacy (mean =73.8; SD=9.2) versus moderate (50%) efficacy (mean =40.4; SD=20.2). Among 13 studies (n=5023) included in meta-analysis, efficacy and non 'risk group' membership had medium effect sizes, and pragmatic obstacles, cost, perceived susceptibility to HIV infection, side effects/safety concerns, fear of vaccines, perceived vaccine benefits, duration of protection, and ethnicity had small effect sizes on HIV vaccine acceptability. Public health strategies to promote the benefits of partial efficacy HIV vaccines and accurate HIV risk perceptions, and to dispel vaccine fears, along with structural interventions to subsidize vaccine costs and facilitate access, may increase future HIV vaccine uptake and, in turn, the effectiveness of HIV vaccines in controlling the epidemic.Keywords
This publication has 51 references indexed in Scilit:
- HIV Vaccine Trial Results — An Opening for Further ResearchNew England Journal of Medicine, 2009
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in ThailandNew England Journal of Medicine, 2009
- Preventive HIV Vaccine Acceptability and Behavioral Risk Compensation among a Random Sample of High‐Risk Adults in Los Angeles (LA VOICES)Health Services Research, 2009
- HIV Vaccine Research: The Way ForwardScience, 2008
- Assessing heterogeneity in meta-analysis: Q statistic or I² index?Psychological Methods, 2006
- Assessing the Attitudes, Knowledge, and Awareness of HIV Vaccine Research Among Adults in the United StatesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- Factors associated with the acceptance of an AIDS vaccine: an exploratory studyPreventive Medicine, 2004
- Correlates of negative intent to receive an AIDS vaccine: an exploratory studyInternational Journal of STD & AIDS, 2004
- HIV Vaccines: A Global PerspectiveCurrent Molecular Medicine, 2003
- Key Issues for a Potential Human Immunodeficiency Virus VaccineClinical Infectious Diseases, 2003